Laura Sutcliffe

Stock Analyst at UBS

(1.26)
# 1613
Out of 5,327 analysts
8
Total ratings
60.00%
Success rate
15.84%
Average return
6 Stocks
Name Action PT Current % Upside Ratings Updated
RMD ResMed
Maintains: Buy
290 285
237.74 19.88% 1 Apr 24, 2025
TLX Telix Pharmaceutical...
Maintains: Strong Buy
21 22
17.41 26.36% 2 Jan 27, 2025
UCBJY UCB
Upgrades: Buy
n/a
n/a n/a 1 Aug 23, 2021
ARGX argenx
Initiates Coverage On: Buy
390
629.84 -38.08% 1 Jun 18, 2021
GNHAF Vifor Pharma AG
Upgrades: Neutral
n/a
n/a n/a 1 Mar 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 20, 2019